Chemika will be exhibiting at the PDA Aseptic Manufacturing Excellence Conference on October 13-14, 2025.
Our Managing Director, Alan Doughty and Laura Piva will be at our booth to disc...
We’re thrilled to announce that Alan Doughty (Managing Director & Chief Chemist)
Chemika has expanded its leachables and extractables testing services with the recent commissioning of a triple quadrupole LCMS system.
We have been conducting extractabl...
With the latest in LCMS technology, Chemika has commenced testing of pharmaceutical materials for nitrosamines. Methods have been established for a number of critical small molecule nitrosamines and we have the capability to test for ingredient...
Effective from the 3rd of November, Stephanie LeStrange has been promoted to the position of Laboratory Services Manager replacing Richard Miller in the role.
For the past few years, Stephanie has been employed in the role of Laboratory Operations ...
Chemika has been a proud sponsor of St Kilda Cycling Club over the past three years and have recently extended their sponsorship until 2027.
St Kilda Cycling Club has celebrated GOLD at the recent Olymp...
Chemika is proud to be a sponsor at the 2024 PharmOut Pharma and Device Forum.
Our Managing Director and Chief Chemist, Alan Doughty, Quality Manager, Catherine Micallef, Laboratory Operations Leader, S...
Stability testing of new medical products or products in early stage clinical trial is one of the services offered by Chemika. Shelf life studies are complemented by method development and validation which allow our customers to register medicines or comm...
In late April Chemika was the subject of an FDA audit of our operation. We have been registered as a facility with the FDA since November 2021, and this is the first time the FDA have travelled to audit us. Over the course of 3 days the auditor identified...
